Clinical Trial Update: Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies [NA]

View source ↗

Summary

Clinical trial update for 177Lu-CTR-FAPI in advanced metastatic digestive cancers; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Stomach
• Colorectal Cancer
• Neuroendocrine Tumor
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• 177Lu-CTR-FAPI

Snippet

Sponsor: Xijing Hospital | Conditions: Pancreatic Ductal Adenocarcinoma (PDAC), Adenocarcinoma of the Stomach | NA | Status: NOT_YET_RECRUITING